Skip to content

Membrane Sweeping in Early Labor and Delivery Outcomes

Membrane Sweeping in Early Labor and Delivery Outcomes

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03517696
Enrollment
0
Registered
2018-05-07
Start date
2018-05-20
Completion date
2020-02-25
Last updated
2020-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Labor

Brief summary

Membrane sweeping is a routine procedure in obstetrics in term patients. It has been shown to be effective in decreasing post term gestation and in increasing rate of spontaneous vaginal delivery when used in setting of induction of labor in nulliparous patients. The goal of this study is to determine if membranes sweeping in early labor is effective in improving delivery outcomes including decreasing rate of cesarean section.

Detailed description

This is a non-blinded randomized controlled trial. Participants will be recruited at time of presentation to triage for labor evaluation after cervical exam. Patients with a term, singleton pregnancy who present with regular, painful contractions and a Bishop score \< 7 will be recruited to the study. A random number generator will be used to create a list of random binary numbers. If the patient agrees to the study, the random number list will be used to assign the participant to membrane sweeping or no membrane sweeping. Participants assigned to membrane sweeping will have an additional exam during their initial evaluation in which the membranes will be separated from the cervix and lower part of the uterus with a finger inserted into the cervical os. This would be done with at least one rotation counterclockwise and one rotation clockwise. Those not assigned to membrane sweeping will not have an additional exam. Patients will then be managed as per their primary Obstetrics (OB) provider with the exception of no further membrane sweeping throughout the labor course. Participants are only required to participate during initial evaluation and randomization. No extra study visits are required. Due to the nature of the intervention, which requires a provider to perform a procedure, blinding will not be possible for this trial. No therapy will be withheld for any patients. Their labor course will be managed as per their primary provider using standards of care. Non-treatment group is necessary in order to exam the difference of effects between membrane sweeping and no membrane sweeping. Patients will be removed from the study if they chose to withdraw their participation. Participants will resume care as normal regardless of withdrawing study participation.

Interventions

Participants assigned to membrane sweeping will have an additional exam during their initial evaluation in which the membranes will be separated from the cervix and lower part of the uterus with a finger inserted into the cervical os. This would be done with at least one rotation counterclockwise and one rotation clockwise.

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Intervention is not able to be blinded

Intervention model description

Non-blinded Randomized Controlled Trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Singleton pregnancy at or after 39 weeks gestation, intact membranes, cephalic presentation, nulliparous, Bishop score \<7, English or Spanish speaking

Exclusion criteria

* Prior uterine surgery precluding vaginal delivery, maternal condition precluding vaginal delivery, fetal anomaly, prior membrane stripping

Design outcomes

Primary

MeasureTime frameDescription
Decrease in Cesarean delivery rateUp to 3 weeksDecrease in Cesarean delivery rate

Secondary

MeasureTime frameDescription
Time to deliveryUp to 3 weeksLength of labor from randomization to delivery
Operative vaginal delivery rateUp to 3 weeksAssess a decrease in operative vaginal delivery
Labor augmentation rate reductionUp to 3 weeksAssess the reduction in the rate of labor augmentation ( via the use of oxytocin and/or amniotomy)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026